GW Pharmaceuticals Limited

GW Pharmaceuticals Limited, headquartered in Great Britain, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Jazz Pharmaceuticals plc, which may influence its climate commitments and reporting practices.

As of now, GW Pharmaceuticals has not established any documented reduction targets or specific climate pledges. The lack of emissions data and reduction initiatives suggests that the company may be in the early stages of developing its climate strategy or may rely on the broader commitments of its parent company, Jazz Pharmaceuticals plc.

Given the context of the pharmaceutical industry, it is essential for companies like GW Pharmaceuticals to align with industry standards and best practices in climate action. This includes potentially adopting science-based targets and engaging in initiatives that promote sustainability and carbon footprint reduction.

In summary, while GW Pharmaceuticals Limited does not currently provide specific emissions data or reduction targets, its affiliation with Jazz Pharmaceuticals plc may play a role in shaping its future climate commitments.